• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部非结核分枝杆菌患者在治疗起始方面的语言和种族差异。

Language and racial disparities in treatment initiation for patients with pulmonary non-tuberculous mycobacteria.

作者信息

Asupoto Olabimpe, Anwar Shamsuddin, Westgard Leo K, Alsoubani Majd, Vindenes Tine, Wurcel Alysse G

机构信息

Department of Medicine, Division of Geographic Medicine and Infectious Diseases, Tufts Medicine, Boston, MA, USA.

Department of Medicine, Boston Medical Center, Boston, MA, USA.

出版信息

BMC Res Notes. 2025 Mar 1;18(1):89. doi: 10.1186/s13104-025-07126-1.

DOI:10.1186/s13104-025-07126-1
PMID:40025546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11871829/
Abstract

OBJECTIVE

Disparities in testing and treatment of pulmonary nontuberculous mycobacteria (P-NTM) warrant further investigation into language and race's impact on treatment initiation. The objective of the study is to compare the length of treatment initiation for P-NTM patients assessed in the pulmonary and infectious diseases clinics through language and race.

RESULTS

The cohort included 63 patients; 28 patients received treatment, and 35 patients did not receive treatment. According to the IDSA/ATS guidelines for diagnosis of pulmonary NTM, 55% of patients met all three categories, 40% of patients did not fulfill all three categories and 5% of patient charts were inconclusive. Charts were considered inconclusive if a comprehensive NTM evaluation was not conducted, such as no CT imaging, only one culture sent, or lost to follow up.

摘要

目的

肺非结核分枝杆菌(P-NTM)检测与治疗方面的差异值得进一步研究语言和种族对治疗启动的影响。本研究的目的是通过语言和种族比较在肺病和传染病诊所评估的P-NTM患者开始治疗的时长。

结果

该队列包括63例患者;28例患者接受了治疗, 35例患者未接受治疗。根据美国感染病学会(IDSA)/美国胸科学会(ATS)的肺NTM诊断指南,55%的患者符合所有三个类别,40%的患者未满足所有三个类别,5%的患者病历结果不明确。如果未进行全面的NTM评估,如未进行CT成像、仅送检一份培养物或失访,则病历结果被视为不明确。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a56/11871829/109573584e26/13104_2025_7126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a56/11871829/109573584e26/13104_2025_7126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a56/11871829/109573584e26/13104_2025_7126_Fig1_HTML.jpg

相似文献

1
Language and racial disparities in treatment initiation for patients with pulmonary non-tuberculous mycobacteria.肺部非结核分枝杆菌患者在治疗起始方面的语言和种族差异。
BMC Res Notes. 2025 Mar 1;18(1):89. doi: 10.1186/s13104-025-07126-1.
2
Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.影响HIV阴性患者非结核分枝杆菌肺部感染治疗起始的因素;一项多中心观察性研究。
Respir Med. 2016 Nov;120:101-108. doi: 10.1016/j.rmed.2016.10.001. Epub 2016 Oct 6.
3
Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2025 Mar 27;3(3):CD016039. doi: 10.1002/14651858.CD016039.
4
Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia.俄罗斯阿尔汉格尔斯克地区肺部非结核分枝杆菌病患者的诊断和治疗。
Infect Genet Evol. 2019 Sep;73:358-361. doi: 10.1016/j.meegid.2019.05.022. Epub 2019 Jun 1.
5
Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.非结核分枝杆菌肺病一年改善情况的预测因素:一项为期11年的回顾性多中心研究。
PLoS Negl Trop Dis. 2017 Aug 7;11(8):e0005841. doi: 10.1371/journal.pntd.0005841. eCollection 2017 Aug.
6
Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014.非结核分枝杆菌肺部感染管理指南是否得到尊重,以及对患者有何影响?2007 年至 2014 年法国的一项回顾性研究。
Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):233-240. doi: 10.1007/s10096-017-3120-7. Epub 2017 Oct 24.
7
Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.中国南京地区非结核分枝杆菌肺病的特征。
BMC Infect Dis. 2019 Sep 2;19(1):764. doi: 10.1186/s12879-019-4412-6.
8
Nontuberculous mycobacteria and the lung: from suspicion to treatment.非结核分枝杆菌与肺部:从怀疑到治疗。
Lung. 2010 Aug;188(4):269-82. doi: 10.1007/s00408-010-9240-9. Epub 2010 Apr 9.
9
Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010.北卡罗来纳州中部居民中分离出的非结核分枝杆菌的流行病学研究,2006-2010 年。
J Infect. 2016 Jun;72(6):678-686. doi: 10.1016/j.jinf.2016.03.008. Epub 2016 Mar 18.
10
Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.非结核分枝杆菌:参考实验室的流行病学模式及与肺部疾病相关的危险因素。
Epidemiol Infect. 2017 Feb;145(3):515-522. doi: 10.1017/S0950268816002521. Epub 2016 Nov 2.

本文引用的文献

1
Nontuberculous Mycobacterial Infection in Wisconsin Adults and Its Relationship to Race and Social Disadvantage.威斯康星州成年人的非结核分枝杆菌感染及其与种族和社会劣势的关系。
Ann Am Thorac Soc. 2023 Aug;20(8):1107-1115. doi: 10.1513/AnnalsATS.202205-425OC.
2
Racial and ethnic differences in patients enrolled in the national bronchiectasis and nontuberculous mycobacteria research registry.在国家支气管扩张和非结核分枝杆菌研究注册中心注册的患者中存在种族和民族差异。
Respir Med. 2023 Apr;209:107167. doi: 10.1016/j.rmed.2023.107167. Epub 2023 Feb 16.
3
Pathophysiology of pulmonary nontuberculous mycobacterial (NTM) disease.
肺部非结核分枝杆菌(NTM)病的病理生理学
Respir Investig. 2023 Mar;61(2):135-148. doi: 10.1016/j.resinv.2022.12.002. Epub 2023 Jan 12.
4
Racial Disparities in Lung Cancer Stage of Diagnosis Among Adults Living in the Southeastern United States.美国东南部成年人肺癌诊断阶段的种族差异。
Chest. 2023 May;163(5):1314-1327. doi: 10.1016/j.chest.2022.11.025. Epub 2022 Nov 24.
5
Specialty Care Utilization Among Adults with Limited English Proficiency.成人有限英语能力者的专业护理利用情况。
J Gen Intern Med. 2022 Dec;37(16):4130-4136. doi: 10.1007/s11606-022-07477-6. Epub 2022 Mar 29.
6
Delays in Care Associated With Non-English-Speaking Patients With Breast Cancer.与非英语母语乳腺癌患者相关的护理延误
J Natl Compr Canc Netw. 2021 Aug 10. doi: 10.6004/jnccn.2020.7797.
7
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.非结核分枝杆菌肺病的治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学与感染病学会/美国感染病学会官方临床实践指南
Eur Respir J. 2020 Jul 7;56(1). doi: 10.1183/13993003.00535-2020. Print 2020 Jul.
8
Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.肺外非结核分枝杆菌病的治疗
Infect Chemother. 2019 Sep;51(3):245-255. doi: 10.3947/ic.2019.51.3.245.
9
Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病治疗结局定义中的未解决问题。
Eur Respir J. 2019 May 23;53(5). doi: 10.1183/13993003.01636-2018. Print 2019 May.
10
Unilateral Lung Involvement of Nodular Bronchiectatic Complex Pulmonary Diseases: Proportion and Evolution on Serial CT Studies.结节性支气管扩张复杂肺部疾病的单侧肺受累:系列CT研究中的比例及演变
AJR Am J Roentgenol. 2019 May;212(5):1010-1017. doi: 10.2214/AJR.18.20589. Epub 2019 Feb 26.